UBS boss Ermotti fears Europe’s banks ‘too small to survive’
November 13, 2019Alibaba launches $13.4 billion Hong Kong listing to fund expansion
November 13, 2019Biotech-for-hire PeptiDream charts new path and becomes short target
at
The promise of PeptiDream Inc’s drug-discovery technology and its lucrative research-for-hire contracts have made it a darling of the Tokyo stock market. Now, those gains have made it a target for short-seller Muddy Waters.
Powered by WPeMatico
